Confirmation of Association Between Cystic Fluid Analysis With Pancreatic Cystic Lesions

Last updated: August 10, 2022
Sponsor: Seoul National University Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Pancreatitis

Treatment

N/A

Clinical Study ID

NCT05497271
H-2206-213-1336
  • Ages > 18
  • All Genders

Study Summary

Through a comprehensive analysis of the pancreatic cystic fluid analysis, the role of the cystic fluid analysis is confirmed in terms of accurate diagnosis of pancreatic cysts, appropriate prediction of treatment response, and to select proper treatment indication through analytic results.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. patients who diagnosed with pancreatic cystic lesion
  2. patients who are able to acquire cystic fluid through EUS-FNA or surgery
  3. patients aged 18 years and older

Exclusion

Exclusion Criteria:

  1. patients who did not want to participate in this study
  2. patients aged under 18 years old
  3. severely mentally ill patients
  4. pregnant women

Study Design

Total Participants: 500
Study Start date:
January 01, 2017
Estimated Completion Date:
December 31, 2025

Connect with a study center

  • Seoul National University Hospital

    Seoul, 101
    Korea, Republic of

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.